Biosion Presents Discovery and Development Data at PEGS for its Anti-CD40 Agonistic Antibody
- Written by PR Newswire
NEWARK, Del. and NANJING, China, May 8, 2023 /PRNewswire/ -- Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced the upcoming presentation of discovery and development data for BSI-038, an anti-CD40 agonistic antibody at the PEGS Boston conference to be held from May 15 to 19, 2023.
BSI-...